Divisions

Neo Science Diagnostic LLC - Oman

NIPT technology is a scientific discovery that there is fetal free baby DNA in the peripheral blood of pregnant mothers. As early as 1997, scientists have discovered fetal free DNA fragments in the blood of pregnant women. Therefore, it is not a false statement that the mother and the child are connected with each other.

NIPT is a non-invasive fetal chromosomal abnormality prenatal testing technique and a non-invasive fetal chromosome aneuploidy detection technique. NIPT Is a technology to detect from mother Peripheral blood if the feats have any fetal aneuploidy.

By collecting the peripheral blood of pregnant women, the free DNA fragments of the featus baby (including fetal free DNA) in the plasma of maternal peripheral blood are sequenced, and combined with bioinformatics analysis, the risk of fetal aneuploidy is calculated.

 

 


 

NIPT can detect

  • Trisomy 21 Down syndrome
  • Trisomy 18 Edwards' syndrome
  • Trisomy 13 Patau syndrome
  • Sexulat aneuploidies (Sex of Fetas)
  • chromosome aneuploidies
  • chromosome deletions/repeats.
  • NIFTY can detect all 23 pairs of Chromosomes, and reports for: T21, T18, T13, T9, T16, T22, XO, XXY, XXX, XYY, 60+ Microdeletions, Aneuploidies of chromosomes.

It is a non-invasive sampling, no abortion risk, high sensitivity and high accuracy.

When to Get NIPT Test

Pregnant women in the following situations are: 

  • pregnant women who are 32 years old
  • Ultrasound results show aneuploidy high risk
  • Have a child with genetic diseases.
  • Early pregnancy, mid-pregnancy or triple screening, quadruple screening showed positive aneuploidy results
  • pregnant women who have direct indications of prenatal diagnosis
  • Pregnant women with high body weight (weight greater than 80 kg).
  • Pregnant women who are pregnant by in invitro fertilization-embryo transfer (IVF)
  • Pregnant women with twin pregnancy.
  • Pregnant women with malignant tumors.
  • Chromosome abnormal fetal birth
  • Pregnant women with a clear chromosomal abnormality on either of couple's side.
  • Fetal B-ultrasound is suspected of being 

How Early Can NIPT Test be done

Then NIPT technology has advantages over traditional Down's screening and amniocentesis.  

  1. Early: can be checked from 10th week of pregnancy
  2. Safety: no risk of infection, to avoid fetal intrauterine infection and abortion
  3. Non-Invasive: 10ml mother arm vein blood is taken, no amniocentesis is needed
  4. comprehensive: screening all 23 pairs of chromosomes + scanning micro-deletions
  5. Accurate: The dual-stage NGS next-generation sequencing technology has an accuracy rate of >99.5%.

 

LIST OF TESTS

NIFTY Basic - more than 5,000,000 tests performed worldwide, the worlds most sensitive, robust and trusted Non-Invasive Prenatal Brand. Reports for T21, T18, 13. Sex Chromosome Aneuploidies screened include XO, XXY, XXX, XYY, plus interpretation. Gender Identification.

 
NIFTY Advance - Full-package reporting, includes the basic reporting parameter plus T9, T16, T22, and more than 60 Microdeletion and Duplication Syndromes. Please see (link) to access appendix of tests.
 

NIFTY Twins - Using advanced techniques in the lab, BGI's NIFTY is able to screen for mom's who have twins, too! Reports for T21, T18, and T13, as well as Y Chromosome abnormality.

Contact Details

Neo Science Diagnostic LLC

P.O: Box: 387, PC: 117 Building No.1710, Way No.2728 

Al Munther Building, CBD Area, Ruwi, Muscat, Sultanate of Oman 

Tel: +968-24791552, Fax: +968-24791627 | Neosceience@gstoman.com

Visit Our Website: http://www.neoscienceoman.com/

 

Sales Contact

Mr.Sarathchandran 
Tel: +968 95098943
sm@gstoman.com

Mr.Ahmed Samir
Tel: +968 97201224
ahmed@gstoman.com

Service Contact

neosceience@gstoman.com